Connecticut Children's Medical Center

Connecticut Children's Medical Center, a Hartford-based tax-exempt hospital and non-profit organization, functions as a recipient and subrecipient of federal research grants from the National Institutes of Health, the Health Resources and Services Administration, and other HHS agencies, with secondary participation in federal contract sub-awards as a clinical research site. The organization does not hold prime federal contracts or sit on government-wide contract vehicles; its federal footprint is anchored in biomedical research and pediatric clinical-trial participation.

The institution's grant portfolio spans pediatric disease research, provider intervention development, and public-health training programs. Prime grant recipients include the National Institute of Diabetes and Digestive and Kidney Diseases (a $782,101 longitudinal study examining pain-related stigma in adolescents with disorders of gut-brain interaction, awarded July 1, 2026, running through March 31, 2031, under CFDA 93.847), the National Heart Lung and Blood Institute (a mentored career-development award supporting intervention research on pediatric sickle cell disease outcomes), the National Cancer Institute (a patient-centered intervention development study on sexual and reproductive health communication in adolescent and young adult oncology patients, awarded July 9, 2024), and the SAMHSA Center for Mental Health Services (a $782,101 grant for the Training to Establish an Alliance Centered on Hope suicide-prevention training program, awarded December 31, 2022, running through September 29, 2026). Connecticut Children's also received a congressionally directed construction award for a new MRI suite upgrade, awarded September 30, 2023 through the Healthcare Systems Bureau, with completion targeted for September 29, 2027.

Customer concentration among the top five HHS agencies and NHTSA accounts for 50 percent of awards. The National Highway Traffic Safety Administration leads by award count (16 awards), driven primarily by sub-recipient work on child-passenger safety and pedestrian awareness campaigns funded through the Connecticut Department of Transportation; the National Institutes of Health and the Health Resources and Services Administration anchor the scientific research footprint across pediatric neurology, infectious disease, sickle cell disease, cancer survivorship, and early childhood development. The organization serves 24 distinct federal agencies in total.

As a subrecipient, Connecticut Children's participates in multi-site clinical research conducted under university prime recipients including the University of Alabama at Birmingham (congenital cytomegalovirus infection studies), the University of North Carolina at Chapel Hill (syphilis specimen collection for diagnostic product development), Duke University (vaccine development and monoclonal antibody production studies), Emory University (integrative training on pediatric sickle cell pain), the University of Pittsburgh (peer support for adolescents with sickle cell pain), the University of Connecticut Health Center and the Connecticut Judicial Branch (sexual abuse medical and domestic violence services), and the Children's Hospital Corporation (natural language processing and health data mining). Sub-grant work emphasizes clinical protocol support, patient screening and enrollment, specimen collection, laboratory work, intervention testing, and dissemination through peer-reviewed publications and conferences.

Activity shows modest growth: nine awards in 2022 increased to eighteen in 2024, before declining to thirteen in 2025 and eleven in 2026. Only three awards face ultimate completion within the next twenty-four months, presenting minimal recompete exposure. Federal contract sub-work captured in the Service Contract Inventory is sparse—two records across FY2024–FY2025 with 0.1 FTEs total—and does not reflect the organization's primary grant-based research footprint. Combined federal dollars obligated across all awards total $315.2 million, though this aggregate masks the distinction between prime grant recipients (where Connecticut Children's controls research direction) and sub-recipient roles (where the organization performs tasks under university and hospital prime awardees). The organization's federal engagement is characteristically that of a specialized pediatric research and clinical-trial center, not a prime contractor or systems vendor.